Epidemiology and clinical presentation of psoriasis in southeast Iran
Keywords:
Psoriasis, Clinical features, southeast IranAbstract
Background Psoriasis is a common chronic inflammatory disease that causes disability and reduces the patient's quality of life. It is a public health challenge because of its serious comorbidities and debilitating component. Methods A retrospective study was done in 2020 at Azfalipour Hospital, Kerman, Iran. All patients hospitalized at this referral hospital from 2015 to 2020 were studied in terms of their demographic data (age, gender, educational status), past medical history, family history, drug history, age at the onset of disease, first presentation of disease, type of psoriasis, body mass index, season of hospitalization, and duration of disease. Results This study examined the 100 patients with psoriasis, with a mean age of 43.67±17.59 years. Nearly two-thirds of the patients were over 25 years old, with the largest age group being patients aged over 55. The longest duration of psoriasis involvement was <10 years. The most common type of lesion in psoriasis patients was the plaque type, followed by the pustular type. The mean age of onset was 35.39±18.32 years, and the most common comorbidity was hypertension. Conclusion The most common type of psoriasis lesions was the plaque type, with a high prevalence in the upper extremities. Nail involvement was seen in half of the patients, while the incidence of oral mucosal involvement was lower than expected. We found normal BMI, viral markers, and lipid profiles in most patients.References
Parisi R, Iskandar IYK, Kontopantelis E, Augustin M, Griffiths CEM, Ashcroft DM. National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study. BMJ. 2020;369:m1590.
Pariser DM, Bagel J, Gelfand JM, Korman NJ, Ritchlin CT, Strober BE, et al. National Psoriasis Foundation clinical consensus on disease severity. Archives of dermatology. 2007;143(2):239-42.
Hägg D, Eriksson M, Sundström A, Schmitt-Egenolf M. The higher proportion of men with psoriasis treated with biologics may be explained by more severe disease in men. PloS one. 2013;8(5):e63619.
Rahman P, Gladman DD, Schentag CT, Petronis A. Excessive paternal transmission in psoriatic arthritis. Arthritis and rheumatism. 1999;42(6):1228-31.
Elder JT. Genome-wide association scan yields new insights into the immunopathogenesis of psoriasis. Genes and immunity. 2009;10(3):201-9.
Elder JT, Bruce AT, Gudjonsson JE, Johnston A, Stuart PE, Tejasvi T, et al. Molecular dissection of psoriasis: integrating genetics and biology. Journal of Investigative Dermatology. 2010;130(5):1213-26.
Nickoloff BJ, Qin JZ, Nestle FO. Immunopathogenesis of psoriasis. Clinical reviews in allergy & immunology. 2007;33(1-2):45-56.
Basavaraj KH, Ashok NM, Rashmi R, Praveen TK. The role of drugs in the induction and/or exacerbation of psoriasis. International journal of dermatology. 2010;49(12):1351-61.
Iskandar I, Parisi R, Griffiths C, Ashcroft D, Atlas GP. Systematic review examining changes over time and variation in the incidence and prevalence of psoriasis by age and gender. British Journal of Dermatology. 2021;184(2):243-58.
Ayala F. Clinical presentation of psoriasis. Reumatismo. 2007;59 Suppl 1:40-5.
Mansouri B, Kivelevitch D, Natarajan B, Joshi AA, Ryan C, Benjegerdes K, et al. Comparison of Coronary Artery Calcium Scores Between Patients With Psoriasis and Type 2 Diabetes. JAMA Dermatology. 2016;152(11):1244-53.
Lerman JB, Joshi AA, Chaturvedi A, Aberra TM, Dey AK, Rodante JA, et al. Coronary plaque characterization in psoriasis reveals high-risk features that improve after treatment in a prospective observational study. Circulation. 2017;136(3):263-76.
Dey AK, Joshi AA, Chaturvedi A, Lerman JB, Aberra TM, Rodante JA, et al. Association Between Skin and Aortic Vascular Inflammation in Patients With Psoriasis: A Case-Cohort Study Using Positron Emission Tomography/Computed Tomography. JAMA Cardiology. 2017;2(9):1013-8.
Armstrong AW, Guérin A, Sundaram M, Wu EQ, Faust ES, Ionescu-Ittu R, et al. Psoriasis and risk of diabetes-associated microvascular and macrovascular complications. Journal of the American Academy of Dermatology. 2015;72(6):968-77. e2.
Dalgard FJ, Gieler U, Tomas-Aragones L, Lien L, Poot F, Jemec GB, et al. The psychological burden of skin diseases: a cross-sectional multicenter study among dermatological out-patients in 13 European countries. Journal of Investigative Dermatology. 2015;135(4):984-91.
Dowlatshahi EA, Wakkee M, Arends LR, Nijsten T. The prevalence and odds of depressive symptoms and clinical depression in psoriasis patients: a systematic review and meta-analysis. Journal of Investigative Dermatology. 2014;134(6):1542-51.
Armstrong AW, Read C. Pathophysiology, clinical presentation, and treatment of psoriasis: a review. Jama. 2020;323(19):1945-60.
Organization WH. World Health Organization global report on psoriasis. Geneva: World Health Association. 2016.
López-Estebaranz JL, Sánchez-Carazo JL, Sulleiro S. Effect of a family history of psoriasis and age on comorbidities and quality of life in patients with moderate to severe psoriasis: Results from the ARIZONA study. The Journal of dermatology. 2016;43(4):395-401.
Solmaz D, Bakirci S, Kimyon G, Gunal EK, Dogru A, Bayindir O, et al. Impact of Having Family History of Psoriasis or Psoriatic Arthritis on Psoriatic Disease. Arthritis care & research. 2020;72(1):63-8.
Egeberg A, Skov L, Joshi AA, Mallbris L, Gislason GH, Wu JJ, et al. The relationship between duration of psoriasis, vascular inflammation, and cardiovascular events. Journal of the American Academy of Dermatology. 2017;77(4):650-6. e3.
Husted JA, Thavaneswaran A, Chandran V, Eder L, Rosen CF, Cook RJ, et al. Cardiovascular and other comorbidities in patients with psoriatic arthritis: a comparison with patients with psoriasis. Arthritis care & research. 2011;63(12):1729-35.
Yeung H, Takeshita J, Mehta NN, Kimmel SE, Ogdie A, Margolis DJ, et al. Psoriasis severity and the prevalence of major medical comorbidity: a population-based study. JAMA dermatology. 2013;149(10):1173-9.
Kim DS, Shin D, Lee MS, Kim HJ, Kim DY, Kim SM, et al. Assessments of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in Korean patients with psoriasis vulgaris and psoriatic arthritis. The Journal of dermatology. 2016;43(3):305-10.
Ma C, Harskamp C, Armstrong E, Armstrong A. The association between psoriasis and dyslipidaemia: a systematic review. British Journal of Dermatology. 2013;168(3):486-95.
Kanada K, Schupp C, Armstrong A. Association between psoriasis and viral infections in the United States: focusing on hepatitis B, hepatitis C and human immunodeficiency virus. Journal of the European Academy of Dermatology and Venereology. 2013;27(10):1312-6.
Kharawala S, Golembesky AK, Bohn RL, Esser D. The clinical, humanistic, and economic burden of generalized pustular psoriasis: a structured review. Expert review of clinical immunology. 2020;16(3):239-52.
Choon SE, Lai NM, Mohammad NA, Nanu NM, Tey KE, Chew SF. Clinical profile, morbidity, and outcome of adult‐onset generalized pustular psoriasis: analysis of 102 cases seen in a tertiary hospital in Johor, Malaysia. International journal of dermatology. 2014;53(6):676-84.
Choi JW, Kim BR, Seo E, Youn SW. Identification of nail features associated with psoriasis severity. The Journal of dermatology. 2017;44(2):147-53.
Darwazeh AM, Al-Aboosi MM, Bedair AA. Prevalence of oral mucosal lesions in psoriatic patients: A controlled study. Journal of clinical and experimental dentistry. 2012;4(5):e286-91.
Talaee R, Hajheydari Z, Moghaddam AY, Moraveji SA, Ravandi BF. Prevalence of Oral Mucosal Lesions and Their Association with Severity of Psoriasis among Psoriatic Patients Referred To Dermatology Clinic: A Cross-Sectional Study in Kashan/Iran. Open access Macedonian journal of medical sciences. 2017;5(7):978-82.
Tollefson MM, Crowson CS, McEvoy MT, Maradit Kremers H. Incidence of psoriasis in children: a population-based study. J Am Acad Dermatol. 2010;62(6):979-87.
